237 related articles for article (PubMed ID: 32365486)
1. Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18.
Neumann A; Engel V; Mahardhika AB; Schoeder CT; Namasivayam V; Kieć-Kononowicz K; Müller CE
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365486
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.
Schoeder CT; Kaleta M; Mahardhika AB; Olejarz-Maciej A; Łażewska D; Kieć-Kononowicz K; Müller CE
Eur J Med Chem; 2018 Jul; 155():381-397. PubMed ID: 29902723
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations.
Jung SW; Cho AE; Yu W
Sci Rep; 2018 Sep; 8(1):13787. PubMed ID: 30213978
[TBL] [Abstract][Full Text] [Related]
4. A GPR18-based signalling system regulates IOP in murine eye.
Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.
Schoeder CT; Mahardhika AB; Drabczyńska A; Kieć-Kononowicz K; Müller CE
ACS Med Chem Lett; 2020 Oct; 11(10):2024-2031. PubMed ID: 33062188
[TBL] [Abstract][Full Text] [Related]
6. Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.
Console-Bram L; Brailoiu E; Brailoiu GC; Sharir H; Abood ME
Br J Pharmacol; 2014 Aug; 171(16):3908-17. PubMed ID: 24762058
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of agonist-bound human cannabinoid receptor CB
Hua T; Vemuri K; Nikas SP; Laprairie RB; Wu Y; Qu L; Pu M; Korde A; Jiang S; Ho JH; Han GW; Ding K; Li X; Liu H; Hanson MA; Zhao S; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Nature; 2017 Jul; 547(7664):468-471. PubMed ID: 28678776
[TBL] [Abstract][Full Text] [Related]
8. Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity.
Sotudeh N; Morales P; Hurst DP; Lynch DL; Reggio PH
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075933
[TBL] [Abstract][Full Text] [Related]
9. Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
McHugh D; Page J; Dunn E; Bradshaw HB
Br J Pharmacol; 2012 Apr; 165(8):2414-24. PubMed ID: 21595653
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors.
Dutta S; Selvam B; Das A; Shukla D
J Biol Chem; 2022 Apr; 298(4):101764. PubMed ID: 35227761
[TBL] [Abstract][Full Text] [Related]
11. Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity.
Mahardhika AB; Załuski M; Schoeder CT; Boshta NM; Schabikowski J; Perri F; Łażewska D; Neumann A; Kremers S; Oneto A; Ressemann A; Latacz G; Namasivayam V; Kieć-Kononowicz K; Müller CE
J Med Chem; 2024 Jun; ():. PubMed ID: 38885438
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of partial activation of cannabinoid receptor type 2 and identification of potential partial agonists: Molecular dynamics simulation and structure-based virtual screening.
Uba AI; Aluwala H; Liu H; Wu C
Comput Biol Chem; 2022 Aug; 99():107723. PubMed ID: 35850049
[TBL] [Abstract][Full Text] [Related]
13. Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders.
Frankowska M; Wydra K; Suder A; Zaniewska M; Gawliński D; Miszkiel J; Furgała-Wojas A; Sałat K; Filip M; Müller CE; Kieć-Kononowicz K; Kotańska M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240392
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor.
Jakowiecki J; Filipek S
J Chem Inf Model; 2016 Dec; 56(12):2457-2466. PubMed ID: 27966915
[TBL] [Abstract][Full Text] [Related]
15. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
16. The Hydrophobic Ligands Entry and Exit from the GPCR Binding Site-SMD and SuMD Simulations.
Jakowiecki J; Orzeł U; Chawananon S; Miszta P; Filipek S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326322
[TBL] [Abstract][Full Text] [Related]
17. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.
Floresta G; Apirakkan O; Rescifina A; Abbate V
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200181
[TBL] [Abstract][Full Text] [Related]
18. GPR18 and GPR55-related Ligands Serving as Antagonists or Agonists: Current Situation, Challenges and Perspectives.
Zhang L; Fang Y; Hang S; Wu W; Sheng R; Guo R
Med Chem; 2023; 19(9):838-847. PubMed ID: 37038675
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
20. Docking and MD study of histamine H4R based on the crystal structure of H1R.
Feng Z; Hou T; Li Y
J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
